As compared to the control group, patients in the CAD group are older, have a higher BMI, longer duration of T2DM and higher systolic blood pressure (SBP), a higher prevalence of current smoking, and higher insulin use (Table 1). The gene discussed is INS; the disease is type 2 diabetes mellitus.